Century Therapeutics, Inc. (NASDAQ: IPSC) reported Q2 EPS of ($0.17), $0.06 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Century Therapeutics, Inc. (IPSC) click here.